Article

VA testing app debuts on iPad

A feature-rich FLEX visual acuity (VA) app for ophthalmology, optometry, clinical trials, and other medical uses has been released on Apple iTunes for retina display iPad devices as an add-in to Konan Medical’s Chart2020 Duo app.

 

Irvine, CA-A feature-rich FLEX visual acuity (VA) app for ophthalmology, optometry, clinical trials, and other medical uses has been released on Apple iTunes for retina display iPad devices as an add-in to Konan Medical’s Chart2020 Duo app.

The app allows clinicians to adjust VA test parameters to test from 33 cm (14 inches) to 6 m (20 ft.), and includes industry standard, Sloan specification literate, illiterate, and pediatric optotypes for western and 6 global languages. The app is also gesture-driven to display acuity lines, single letters, and full charts, including smart randomization and reverse contract on retina display iPad devices.

“(The app) marks a new chapter in our vision assessment products, bringing professional-grade VA tests onto high resolution mobile devices, such as Apple’s retina display iPads,” said Charles Wm. Stewart, OD, chief executive officer of Konan Medical USA. “We have previewed (the app) with ophthalmologists and optometrists for standard VA testing, out of office screenings, clinical trials, school nurses, and even with emergency rooms physicians to bring the vision tests to patients.”

Konan is making complementary apps available, in quantities limited by Apple’s terms and conditions, to academic institutions, optometry students, ophthalmology residents, and other qualified settings.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.